Topic: Direct To Consumer Advertising

The prevalence of pharmaceutical advertising on American television is identified as a primary driver of media bias. The U.S. and New Zealand are noted as the only countries allowing direct-to-consumer drug ads. The enthusiasm of TV medical contributors is compared to a "fee schedule" for scripted reactions, potentially rewarded with industry perks or "swag bags."

The pharmaceutical industry's influence over television news is identified as a "third rail" that media figures are forbidden from touching. Tucker Carlson's monologues criticizing direct-to-consumer drug advertising and the legal immunity granted to vaccine manufacturers are cited as potential factors in his removal. The United States remains one of only two countries globally that allows pharmaceutical companies to advertise directly to the public.

Pharmaceutical companies have expanded direct-to-consumer advertising to include pet medications like Simparica Trio, which carries warnings for neurological adverse reactions in dogs. The prevalence of these ads in the U.S. dates back to 1997, when the FDA, under Commissioner David Kessler, eased rules regarding the disclosure of side effects in broadcast commercials. Kessler currently serves as the Chief Science Officer for the White House COVID-19 Response Team.

A correlation is proposed between the rise of school shootings and the 1997 legalization of direct-to-consumer pharmaceutical advertising on television. While some point to the 1980 creation of the Department of Education, others highlight the increased use of Ritalin and psychiatric drugs in the mid-1990s. The first major modern school shooting, Columbine, occurred in 1999 following these industry shifts.